Literature DB >> 27437079

Charged Nonclassical Antifolates with Activity Against Gram-Positive and Gram-Negative Pathogens.

Eric Scocchera1, Stephanie M Reeve1, Santosh Keshipeddy1, Michael N Lombardo1, Behnoush Hajian1, Adrienne E Sochia2, Jeremy B Alverson2, Nigel D Priestley2, Amy C Anderson1, Dennis L Wright1.   

Abstract

Although classical, negatively charged antifolates such as methotrexate possess high affinity for the dihydrofolate reductase (DHFR) enzyme, they are unable to penetrate the bacterial cell wall, rendering them poor antibacterial agents. Herein, we report a new class of charged propargyl-linked antifolates that capture some of the key contacts common to the classical antifolates while maintaining the ability to passively diffuse across the bacterial cell wall. Eight synthesized compounds exhibit extraordinary potency against Gram-positive S. aureus with limited toxicity against mammalian cells and good metabolic profile. High resolution crystal structures of two of the compounds reveal extensive interactions between the carboxylate and active site residues through a highly organized water network.

Entities:  

Keywords:  Dihydrofolate reductase; Escherichia coli; MRSA; Staphylococcus aureus; antifolate; methotrexate; trimethoprim

Year:  2016        PMID: 27437079      PMCID: PMC4948012          DOI: 10.1021/acsmedchemlett.6b00120

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  23 in total

1.  Physicochemical properties of antibacterial compounds: implications for drug discovery.

Authors:  Rosemarie O'Shea; Heinz E Moser
Journal:  J Med Chem       Date:  2008-02-09       Impact factor: 7.446

2.  Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.

Authors:  R Li; R Sirawaraporn; P Chitnumsub; W Sirawaraporn; J Wooden; F Athappilly; S Turley; W G Hol
Journal:  J Mol Biol       Date:  2000-01-14       Impact factor: 5.469

3.  A β-(1,2)-glycosynthase and an attempted selection method for the directed evolution of glycosynthases.

Authors:  David L Jakeman; Ali Sadeghi-Khomami
Journal:  Biochemistry       Date:  2011-11-03       Impact factor: 3.162

4.  Old yellow enzyme at 2 A resolution: overall structure, ligand binding, and comparison with related flavoproteins.

Authors:  K M Fox; P A Karplus
Journal:  Structure       Date:  1994-11-15       Impact factor: 5.006

5.  Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase.

Authors:  Kathleen M Frey; Michael N Lombardo; Dennis L Wright; Amy C Anderson
Journal:  J Struct Biol       Date:  2009-12-21       Impact factor: 2.867

Review 6.  Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.

Authors:  Jennifer Le; Jay M Lieberman
Journal:  Pharmacotherapy       Date:  2006-12       Impact factor: 4.705

7.  Resistance to methotrexate due to AcrAB-dependent export from Escherichia coli.

Authors:  S J Kopytek; J C Dyer; G S Knapp; J C Hu
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.

Authors:  Jameson B Wood; Donald B Smith; Errol H Baker; Stephen M Brecher; Kalpana Gupta
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

9.  Cancer chemotherapy: targeting folic acid synthesis.

Authors:  Nicole Hagner; Markus Joerger
Journal:  Cancer Manag Res       Date:  2010-11-19       Impact factor: 3.989

10.  Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes.

Authors:  Kishore Viswanathan; Kathleen M Frey; Eric W Scocchera; Brooke D Martin; P Whitney Swain Iii; Jeremy B Alverson; Nigel D Priestley; Amy C Anderson; Dennis L Wright
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

View more
  13 in total

1.  Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.

Authors:  Behnoush Hajian; Eric Scocchera; Carolyn Shoen; Jolanta Krucinska; Kishore Viswanathan; Narendran G-Dayanandan; Heidi Erlandsen; Alexavier Estrada; Katarína Mikušová; Jana Korduláková; Michael Cynamon; Dennis Wright
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

Review 2.  Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs.

Authors:  Bharath Srinivasan; Sam Tonddast-Navaei; Ambrish Roy; Hongyi Zhou; Jeffrey Skolnick
Journal:  Med Res Rev       Date:  2018-09-07       Impact factor: 12.944

3.  Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant Staphylococcus aureus.

Authors:  Stephanie M Reeve; Debjani Si; Jolanta Krucinska; Yongzhao Yan; Kishore Viswanathan; Siyu Wang; Graham T Holt; Marcel S Frenkel; Adegoke A Ojewole; Alexavier Estrada; Sherry S Agabiti; Jeremy B Alverson; Nathan D Gibson; Nigel D Priestley; Andrew J Wiemer; Bruce R Donald; Dennis L Wright
Journal:  ACS Infect Dis       Date:  2019-10-15       Impact factor: 5.084

4.  Charged Propargyl-Linked Antifolates Reveal Mechanisms of Antifolate Resistance and Inhibit Trimethoprim-Resistant MRSA Strains Possessing Clinically Relevant Mutations.

Authors:  Stephanie M Reeve; Eric Scocchera; Jacob J Ferreira; Narendran G-Dayanandan; Santosh Keshipeddy; Dennis L Wright; Amy C Anderson
Journal:  J Med Chem       Date:  2016-06-28       Impact factor: 7.446

5.  MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates.

Authors:  Stephanie M Reeve; Eric W Scocchera; Narendran G-Dayanadan; Santosh Keshipeddy; Jolanta Krucinska; Behnoush Hajian; Jacob Ferreira; Michael Nailor; Jeffrey Aeschlimann; Dennis L Wright; Amy C Anderson
Journal:  Cell Chem Biol       Date:  2016-12-08       Impact factor: 8.116

6.  Direct Substitution of Arylalkynyl Carbinols Provides Access to Diverse Terminal Acetylene Building Blocks.

Authors:  Narendran G-Dayanandan; Eric W Scocchera; Santosh Keshipeddy; Heather F Jones; Amy C Anderson; Dennis L Wright
Journal:  Org Lett       Date:  2016-12-13       Impact factor: 6.005

7.  Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis.

Authors:  Behnoush Hajian; Eric Scocchera; Santosh Keshipeddy; Narendran G-Dayanandan; Carolyn Shoen; Jolanta Krucinska; Stephanie Reeve; Michael Cynamon; Amy C Anderson; Dennis L Wright
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

Review 8.  Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors.

Authors:  Agnieszka Wróbel; Karolina Arciszewska; Dawid Maliszewski; Danuta Drozdowska
Journal:  J Antibiot (Tokyo)       Date:  2019-10-02       Impact factor: 2.649

9.  Structure-Guided In Vitro to In Vivo Pharmacokinetic Optimization of Propargyl-Linked Antifolates.

Authors:  M N Lombardo; N G-Dayanandan; S Keshipeddy; W Zhou; D Si; S M Reeve; J Alverson; P Barney; L Walker; J Hoody; N D Priestley; R S Obach; D L Wright
Journal:  Drug Metab Dispos       Date:  2019-06-14       Impact factor: 3.922

Review 10.  The Concept of Folic Acid in Health and Disease.

Authors:  Yulia Shulpekova; Vladimir Nechaev; Svetlana Kardasheva; Alla Sedova; Anastasia Kurbatova; Elena Bueverova; Arthur Kopylov; Kristina Malsagova; Jabulani Clement Dlamini; Vladimir Ivashkin
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.